本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Acrivon Therapeutics, Inc.

1.37
-0.0350-2.50%
成交量:56.72万
成交额:77.03万
市值:4,279.48万
市盈率:-0.57
高:1.49
开:1.44
低:1.32
收:1.40
数据加载中...
2023/06/22

重要事件披露

Form 8-K - Current report
2023/06/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/05

重要事件披露

Form 8-K - Current report
2023/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/09

重要事件披露

Form 8-K - Current report
2023/05/01

重要事件披露

Form 8-K - Current report
2023/05/01

重要事件披露

Form 8-K - Current report
2023/04/25

重要事件披露

Form 8-K - Current report
2023/03/30

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/03/29

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/03/28

重要事件披露

Form 8-K - Current report
2023/03/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/13

重要事件披露

Form 8-K - Current report
2023/03/03

重要事件披露

Form 8-K - Current report
2023/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2022/12/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2022/11/28

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals